Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Medical Teacher|September 9, 2021
Collaborative healthcare education programmes for continuing professional education in low and middle-income countries: A Best Evidence Medical Education (BEME) systematic review. BEME Guide No. 65Elaine Hill, Dawne Gurbutt, Thamasi Makuloluwa, et al.Plos Neglected Tropical Diseases|December 8, 2021
Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community surveyLloyd Einsiedel, Hai Pham, Mohammad Radwanur Talukder, et al.British Journal of Haematology|October 3, 2002
Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignanciesMichael Hedenus, Sören Hansen, Kerry Taylor, et al.Disability and Rehabilitation|February 25, 2020
Environmental and systemic challenges to delivering services for Aboriginal adults with a disability in Central AustraliaJohn Gilroy, Angela Dew, Rebecca Barton, et al.Leukemia & Lymphoma|October 21, 2003
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphomaAndrew Grigg, Philippe Solal-Celigny, Peter Hoskin, et al.Crime Science|April 2, 2019
Towards a 'smart' cost-benefit tool: using machine learning to predict the costs of criminal justice policy interventionsMatthew Manning, Gabriel T W Wong, Timothy Graham, et al.Journal of Medical Primatology|March 3, 2016
Specific pathogen free macaque colonies: a review of principles and recent advances for viral testing and colony managementJoAnn L Yee, Thomas H Vanderford, Elizabeth S Didier, et al.Blood|April 20, 2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.Cancer|July 4, 2007
Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-alphaSusan Branford, Timothy Hughes, Alvin Milner, et al.American Journal of Hematology|August 29, 2009
An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myelomaRavi Vij, Noemi Horvath, Andrew Spencer, et al.Pageof 8